Drug
Dalteparin
Dalteparin: highest development phase Not Applicable, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dalteparin sodium NCT01050153 | Not Applicable | Venous Thromboembolism |
Latest
No recent events.
Follow Dalteparin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.